DYN logo Dyne Therapeutics : DYN

DYN

Stock Data

$16.58

Change down

$0.13 (0.75%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Dyne Therapeutics Inc is a pioneering biotech firm based in Waltham, Massachusetts, dedicated to developing innovative treatments for a range of genetically driven muscle diseases. With a focus on conditions like myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, the company leverages its proprietary FORCE platform to create therapeutics aimed at modifying the course of these diseases. Founded in 2017, Dyne Therapeutics is at the forefront of addressing unmet needs in muscle disease treatment.

All Dyne Therapeutics Articles

66 Articles

1 2 3 5

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.